publication venue for POLE. -. 2025 Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma.. -. 2025 Case report and review of the literature regarding management of primary uterine primitive neuroectodermal tumors (PNET).. -. 2025